VBI Vaccines, Inc. – (NASDAQ:VBIV) shares saw an uptick in trading volume on Friday . 187,326 shares were traded during mid-day trading, an increase of 129% from the previous session’s volume of 81,805 shares.The stock last traded at $4.05 and had previously closed at $3.90.

Separately, Ladenburg Thalmann began coverage on VBI Vaccines, Inc. – in a research report on Tuesday, July 26th. They issued a “buy” rating for the company.

The stock’s market capitalization is $148.87 million. The stock’s 50 day moving average price is $3.69 and its 200 day moving average price is $3.87.

VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various projects related to human cytomegalovirus (CMV) and other antigens.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.